Navina vs Octagos
Trade coverage lists a USD 55 million Series C for Navina in March 2025, led by Growth Equity at Goldman Sachs Alternatives. Octagos's about and team pages give no founding year, funding or owner, and name Shanti Bansal, MD, a practicing cardiac electrophysiologist, as founder, with a Houston address.
Navina is sold to primary care groups in value-based care, and its customer logos include Privia Health and Agilon Health. Octagos is sold to cardiology clinics with implanted device patients, where Atlas AI filters transmissions, an IBHRE-certified US specialist reviews them, and a physician e-signature completes each report, per the vendor. A primary care group contracting on value and a cardiology clinic with a device queue shop in separate departments, so neither tool is the other's alternative.
Decision support · Reviewed November 2, 2026
When to pick each one
Navina
- Athenahealth, Epic and Veradigm named
- Primary care chart review and HCC suggestions
- Trade coverage lists USD 55M Series C, March 2025
Octagos
- Atlas AI triage plus specialist review of device transmissions
- Epic, Oracle Health, athenahealth, medent, NextGen named
Score
Each row shows points earned of points available under the published rubric.
Navina
36of 100
Octagos
43of 100
| Dimension | Navina | Octagos | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 10 / 10 | 0 |
| EHR integrations (count) | 1.7 / 5.6 | 2.8 / 5.6 | -1.1 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 3.4 / 4.8 | 4.8 / 4.8 | -1.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 14.7 / 21 | -14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 8.4 / 12 | 3 / 12 | +5.4 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 6 / 6 | 0 / 6 | +6 |
Scroll horizontally to see every column.
Pricing
Navina
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Octagos
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Navina
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Octagos
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
2 PubMed records name Octagos.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Navina | Octagos |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | athenahealth, Epic, Veradigm | Epic, Oracle Health, athenahealth, medent, NextGen |
| Founded | 2018 | n/a |
| HQ | n/a | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.